🧠AI AnalysisWeekly Health Roundup: GLP-1 Safety, HIPAA Updates, and FDA Approvals
Recent health reports highlight serious conditions linked to GLP-1 receptor agonists, updated HIPAA response timelines for providers, and new FDA approvals for home-use m…